Product Description

Anti-Influenza A virus HA/Hemagglutinin Reference Antibody (Diridavumab, RUO)

Sizes: 100ug, 1mg

Catalogue Numbers: VK515016-100, VK515016-1000

Lead times: 1-2 weeks, if manufacturer has product in stock

Manufacturer/Ship Location: China

Description: Diridavumab, the alternative name, CR6261, is a human monoclonal antibody directed against influenza A hemagglutinin. The CR6261 antibody was first discovered by the Scripps Institute and Crucell, a Dutch biopharmaceutical company, and later developed by Janssen Pharmaceutical Companies of Johnson & Johnson under the trade name diridavumab. Cr6261 is under investigation in clinical trial NCT02016066 (A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of Diridavumab in Japanese Healthy Participants).

Reactivity: Influenza A virus

Host: Human

Applications: ELISA, Bioactivity: FACS, Functional assay

Alternate Names: CR-6261, CR6261, 1393659-46-5

Clonality: Monoclonal

Isotype: IgG1, lambda

Target: HA/Hemagglutinin

Purification: Protein A/G purified from cell culture supernatant.

Purity: >95% purity as determined by SDS-PAGE.

Expression System: Mammalian Cells

Storage and Stability: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.

Storage Buffer: 0.01M PBS, pH 7.4.

Form: Liquid

Accession: P03455

Endotoxin Level: Please contact the lab for this information.

Research Use Only